MannKind Corporation
Records under this name other than the patents MannKind Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 205 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,040,714 | IRE-1alpha INHIBITORS now held by Fosun Orinove Pharmatech, Inc. In force · High confidence | In force | High confidence | |
| US 11,793,780 | Prodrugs of Treprostinil now held by United Therapeutics Corporation In force · High confidence | In force | High confidence | |
| US 8,166,970 | Inhalation Apparatus Term ended Term ended Nov 9, 2026 · High confidence | Term ended | Term ended Nov 9, 2026 | High confidence |
| US D667,946 | Fluid Transfer Device Term ended Term ended Sep 25, 2026 · High confidence | Term ended | Term ended Sep 25, 2026 | High confidence |
| US 7,799,344 | Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents Term ended Term ended Sep 14, 2026 · High confidence | Term ended | Term ended Sep 14, 2026 | High confidence |
| US 7,803,404 | Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces Term ended Term ended Sep 14, 2026 · High confidence | Term ended | Term ended Sep 14, 2026 | High confidence |
| US 9,066,881 | Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces Term ended Term ended Sep 14, 2026 · High confidence | Term ended | Term ended Sep 14, 2026 | High confidence |
| US 9,089,497 | Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces Term ended Term ended Sep 14, 2026 · High confidence | Term ended | Term ended Sep 14, 2026 | High confidence |
| US 9,283,193 | Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents Term ended Term ended Sep 14, 2026 · High confidence | Term ended | Term ended Sep 14, 2026 | High confidence |
| US 9,446,001 | Increasing Drug Affinity for Crystalline Microparticle Surfaces Term ended Term ended Sep 14, 2026 · High confidence | Term ended | Term ended Sep 14, 2026 | High confidence |